ARAVAX
Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy. The company is using their proprietary technology to reset the immune system to tolerate peanut without evoking allergic reactions during treatment. Aravax was founded in May 2015 through acquisition of intellectual property developed by Alfred Health and Monash University. Aravax has its headquarters in Melbourne, Australia.
ARAVAX
Social Links:
Industry:
Biotechnology Health Care Wellness
Founded:
2015-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.aravax.com.au
Total Employee:
11+
Status:
Active
Contact:
+610396570700
Email Addresses:
[email protected]
Total Funding:
42.2 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Content Delivery Network SSL By Default Mobile Non Scaleable Content HSTS Microsoft Exchange Online
Similar Organizations
iKOR Labs
iKOR Labs is a hemp product extract that protects the body from stress, improves recovery, and helps maintain a positive mental state.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
UbiVac
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.
Current Employees Featured
Founder
Investors List
UniSuper
UniSuper investment in Series B - Aravax
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Aravax
Breakthrough Victoria
Breakthrough Victoria investment in Series B - Aravax
Agati Capital
Agati Capital investment in Series B - Aravax
Uniseed
Uniseed investment in Series B - Aravax
Tenmile
Tenmile investment in Series B - Aravax
Brandon Capital
Brandon Capital investment in Series B - Aravax
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Seed Round - Aravax
Brandon Capital
Brandon Capital investment in Seed Round - Aravax
Official Site Inspections
http://www.aravax.com.au Semrush global rank: 11.51 M Semrush visits lastest month: 156
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Aravax"
ABOUT ARAVAX
Aravax's lead product for peanut allergy (PVX108) is currently being tested in Phase 2 trials in adolescents and children at clinics in Australia and the United …See details»
Aravax - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +610396570700; Aravax …See details»
Aravax Org Chart + Executive Team - The Official Board
See the executive team of Aravax and its org chart, featuring 14 leaders like Pascal Hickey, Rohina Batra and Aled Williams . Toggle navigation The Official Board. Search. Search. ...See details»
Member profile: Aravax | BIA - bioindustry.org
Nov 14, 2024 Aravax is a clinical stage biotechnology company focused on revolutionising the treatment of food allergies with next-generation specific immunotherapies which are safe, …See details»
ARAVAX PTY LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ARAVAX PTY LTD of MELBOURNE, VICTORIA. Get the latest business insights from Dun & Bradstreet.See details»
Aravax - Overview, News & Similar companies | ZoomInfo.com
Aravax contact info: Phone number: +61 396570700 Website: www.aravax.com.au What does Aravax do? Aravax is a clinical-stage biotechnology company focused on developing safe and …See details»
Aravax Company Profile - Office Locations, Competitors, Revenue …
Aravax has 5 employees at their 1 location. See insights on Aravax including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Check Up: Aussie biotech Avarax on the verge of …
Feb 15, 2024 Take Aravax, a Melbourne-based biotech company developing the first safe, convenient, and disease-modifying treatment for peanut allergy. …See details»
Management Team
About aravax. about aravax; management; board of directors; advisors; news. research and development. technology platform; pvx108 for peanut allergy; phase 1 clinical trials (complete) …See details»
Aravax Pty Ltd. - Drug pipelines, Patents, Clinical trials
May 8, 2025 For more information visit: www.aravax.com.au About PVX108 PVX108 is an innovative precision immunotherapy containing a mixture of …See details»
Aravax Pty Ltd. - VentureRadar
Utilizing proprietary platform technology, Aravax aims to precisely reset the immune system to tolerate allergens without causing severe reactions during treatment. The company's lead …See details»
Aravax Melbourne Office: Careers, Perks + Culture | Built In …
Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the …See details»
Australia based Aravax, which is using a peptide based approach …
Feb 21, 2025 Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. …See details»
NEWS - aravax.com.au
Apr 30, 2024 Aravax Completes Recruitment into Phase 2 Study of PVX108, a novel immunotherapy for the Treatment of Peanut Allergy Melbourne, Australia – 28 October 2024: …See details»
Aravax is testing potential new ways to tackle food allergy
Nov 15, 2024 Aravax was founded in 2015 after research from Alfred Health and Monash University showed promise for a new type of peptide immunotherapy to potentially treat …See details»
Aravax - Melbourne Startups
Aravax leverages the expertise of its team, which includes renowned scientists and experienced industry professionals, to advance its research and development efforts. The company is …See details»
Aravax
Aravax is a clinical-stage biotechnology company developing safe, convenient and disease-modifying treatments for food allergies. ... Tel: +61 (0)3 9657 0700 Email: [email protected] ...See details»
Aravax - 2025 Company Profile & Team - Tracxn
Jun 15, 2025 Aravax is a series C company based in Melbourne (Australia), founded in 2015 by Sara Prickett. It operates as a Developer of vaccine for peanut allergy.Aravax has raised …See details»
CONTACT - aravax.com.au
About aravax. about aravax; management; board of directors; advisors; news. research and development. technology platform; pvx108 for peanut allergy; phase 1 clinical trials (complete) …See details»
TECHNOLOGY PLATFORM
Aravax applies proprietary technology and know-how to identify the specific amino acid sequences from allergens which are critical for recognition by human T cells. Allergy-specific …See details»